Keyphrases
Molecular Alterations
100%
Single Institution Study
100%
Thyroid Carcinoma
100%
Molecular Diagnostics
50%
Tumor
33%
Genetic Modification
16%
Clinical Practice
16%
Germ Cells
16%
Poor Differentiation
16%
Driver mutations
16%
Patients with Cancer
16%
Worse Prognosis
16%
Aggressive Disease
16%
Fibroblast Growth Factor Receptor 2 (FGFR2)
16%
Phosphatidylinositol 3-kinase/AKT Signaling Pathway
16%
Li-Fraumeni Syndrome
16%
MLH1
16%
Well-differentiated
16%
Anaplastic
16%
Differentiated Thyroid Carcinoma
16%
MSH2
16%
Papillary Thyroid Carcinoma
16%
Mitogen-activated Protein Kinase 3
16%
Cancer Predisposition Syndrome
16%
Endocrine Malignancies
16%
Actionable mutations
16%
NTRK1
16%
SPECC1L
16%
Aggressive Biological Behavior
16%
Poorly Differentiated Thyroid Carcinoma
16%
NUTM1
16%
NSD3
16%
TPM3
16%
G3BP2
16%
Medicine and Dentistry
Thyroid Carcinoma
100%
Neoplasm
28%
Papillary Thyroid Cancer
14%
Gene Mutation
14%
Phosphoinositide 3-Kinase
14%
Cancer Susceptibility
14%
Molecular Disease
14%
Fibroblast Growth Factor Receptor 2
14%
Poorly Differentiated Thyroid Cancer
14%
Mitogen Activated Protein Kinase Kinase 3
14%
Cancer
14%
Signal Transduction
14%
Li-Fraumeni Syndrome
14%
Germ Cell
14%